Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma (Q40762599)
scientific article
Language:
Current Data About Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma
(P31) (Q13442814)
(P248)
(P698) 8203425
(P813) Saturday, September 23, 2017

(P304) 1677-81; discussion 1681-2
(P248)
(P698) 8203425
(P813) Saturday, September 23, 2017

(P407) (Q1860)

(P433) 6
(P248)
(P698) 8203425
(P813) Saturday, September 23, 2017

(P478) 170
(P248)
(P698) 8203425
(P813) Saturday, September 23, 2017

(P577) Wednesday, June 1, 1994
(P248)
(P698) 8203425
(P813) Saturday, September 23, 2017

(P921) (Q180507)

(Q18936)
(P887)

(Q412415)
(P887)

(P1433) (Q4744256)
(P248)
(P698) 8203425
(P813) Saturday, September 23, 2017

(P1476) "Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma" (language: en)
(P248)
(P698) 8203425
(P813) Saturday, September 23, 2017

(P2093) Smith MR
(P1545) 1
(P248)
(P698) 8203425
(P813) Saturday, September 23, 2017

Peters WA 3rd
(P1545) 2
(P248)
(P698) 8203425
(P813) Saturday, September 23, 2017

Drescher CW
(P1545) 3
(P248)
(P698) 8203425
(P813) Saturday, September 23, 2017

(P2860) (Q69634579)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q40339722)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q38055512)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q67525325)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q70650860)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q40973890)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q68990284)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q39799806)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q28331766)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q71259464)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q71132855)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q67974898)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q68928644)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q46045697)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021

(Q41685752)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970340-X
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article

External Links
(P356) 10.1016/S0002-9378(94)70340-X
(P698) 8203425